Combination Radiation Therapy and Imipridone ONC201 for the Treatment of Solid Tumors

被引：1
|
作者：
Jhawar, S. R. [1 ]
Goyal, S. [2 ]
Thandoni, A. [1 ]
Wu, H. [1 ]
Hassan, S. [3 ]
Schiff, D. S. [1 ]
Allen, J. [4 ]
Stogniew, M. [4 ]
Tarapore, R. [4 ]
Stein, M. [1 ]
Bertino, J. [1 ]
Haffty, B. G., Jr. [1 ]
Zloza, A. [1 ,5 ]
机构：
[1] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA
[2] Rutgers Canc Inst New Jersey, Dept Radiat Oncol, New Brunswick, NJ USA
[3] Rutgers State Univ, New Brunswick, NJ USA
[4] Oncoceutics Inc, Philadelphia, PA USA
[5] Rutgers Robert Wood Johnson Med Sch, Dept Surg, New Brunswick, NJ USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2017年 / 99卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2017.06.2041
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3424
引用
收藏
页码：E598 / E598
页数：1
相关论文
共 50 条
  • [1] Imipridone (ONC201) and Radiation Therapy Combination Shows Promise in Breast Cancer Treatment
    Jhawar, S. R.
    Thandoni, A.
    Goyal, S.
    Wang, S. J.
    Wu, H.
    Hassan, S.
    Schiff, D. S.
    Allen, J.
    Stogniew, M.
    Tarapore, R.
    Bertino, J.
    Haffty, B. G., Jr.
    Zloza, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E180 - E181
  • [2] Imipridone ONC201: combination therapy in hematologic malignancies
    Chari, Ajai
    Barlogie, Bart
    CELL CYCLE, 2018, 17 (16) : 1947 - 1948
  • [3] MDM2 inhibition in combination with imipridone ONC201 treatment as a synergistic combination in solid tumors
    George, Andrew
    Sahin, Ilyas
    Zhang, Shengliang
    Schwermann, Maximilian
    Di Cristofano, Francesca
    DeGeorge, Charlotte
    El-Deiry, Wafik S.
    CANCER RESEARCH, 2023, 83 (07)
  • [4] Combination ONC201 and radiation therapy in the treatment of breast cancer
    Jhawar, Sachin R.
    Schiff, Devora
    Wu, Hao
    Thandoni, Aditya
    Hassan, Suemair
    Allen, Joshua
    Stogniew, Martin
    Tarapore, Rohinton
    Oster, Wolfgang
    Stein, Mark
    Silk, Ann W.
    Goyal, Sharad
    Haffty, Bruce G.
    Zloza, Andrew
    CANCER RESEARCH, 2018, 78 (13)
  • [5] Synergistic antitumor effect of ONC201 in combination with radiation therapy
    Zhou, Lanlan
    Wagner, Jessica
    El-Deiry, Wafik S.
    CANCER RESEARCH, 2018, 78 (13)
  • [6] Treatment and signaling contexts for the application of the imipridone ONC201 to prostate cancer cells
    Amoroso, Francesca
    Pickard, Adam
    Glass, Kimberly
    Tarapore, Rohinton
    Allen, J. E.
    Mills, Ian G.
    CANCER RESEARCH, 2018, 78 (13)
  • [7] The Direct Molecular Target for Imipridone ONC201 Is Finally Established
    Wang, Shaomeng
    Dougan, David A.
    CANCER CELL, 2019, 35 (05) : 707 - 708
  • [8] Discovery and clinical introduction of first-in-class imipridone ONC201
    Allen, Joshua E.
    Kline, C. Leah B.
    Prabhu, Varun V.
    Wagner, Jessica
    Ishizawa, Jo
    Madhukar, Neel
    Lev, Avital
    Baumeister, Marie
    Zhou, Lanlan
    Lulla, Amriti
    Stogniew, Martin
    Schalop, Lee
    Benes, Cyril
    Kaufman, Howard L.
    Pottorf, Richard S.
    Nallaganchu, B. Rao
    Olson, Gary L.
    Al-Mulla, Fahd
    Duvic, Madeleine
    Wu, Gen Sheng
    Dicker, David T.
    Talekar, Mala K.
    Lim, Bora
    Elemento, Olivier
    Oster, Wolfgang
    Bertino, Joseph
    Flaherty, Keith
    Wang, Michael L.
    Borthakur, Gautam
    Andreeff, Michael
    Stein, Mark
    El-Deiry, Wafik S.
    ONCOTARGET, 2016, 7 (45) : 74380 - 74392
  • [9] Predictive biomarker evaluation for the anti-cancer imipridone ONC201
    Morrow, Sara
    Prabhu, Varun Vijay
    Allen, Joshua E.
    Oster, Wolfgang
    CANCER RESEARCH, 2020, 80 (16)
  • [10] ONC201: Stressing tumors to death
    Greer, Yoshimi Endo
    Lipkowitz, Stanley
    SCIENCE SIGNALING, 2016, 9 (415)
12345